Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology
Go back to Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology| (NASDAQ: OCX) | Delayed: 3.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.20 | 52 Week High | $10.24 | |||
| Open | $3.20 | 52 Week Low | $2.45 | |||
| Day High | $3.20 | P/E | N/A | |||
| Day Low | $3.20 | EPS | $-0.46 | |||
| Volume | 74,999 | |||||
